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The use of RNA interference (RNAi) enables the silencing of target genes in plants or plant-
dwelling organisms, through the production of double stranded RNA (dsRNA) resulting in
altered plant characteristics. Expression of properly synthesized dsRNAs in plants can
lead to improved crop quality characteristics or exploit new mechanisms with activity
against plant pests and pathogens. Genetically modified (GM) crops exhibiting resistance
to viruses or insects via expression of dsRNA have received authorization for cultivation
outside Europe. Some products derived from RNAi plants have received a favourable
opinion from the European Food Safety Authority (EFSA) for import and processing in the
European Union (EU). The authorization process in the EU requires applicants to produce
a risk assessment considering food/feed and environmental safety aspects of living
organisms or their derived food and feed products. The present paper discusses the
main aspects of the safety assessment (comparative assessment, molecular
characterization, toxicological assessment, nutritional assessment, gene transfer,
interaction with target and non-target organisms) for GM plants expressing dsRNA,
according to the guidelines of EFSA. Food/feed safety assessment of products from RNAi
plants is expected to be simplified, in the light of the consideration that no novel proteins
are produced. Therefore, some of the data requirements for risk assessment do not apply
to these cases, and the comparative compositional analysis becomes the main source of
evidence for food/feed safety of RNAi plants. During environmental risk assessment, the
analysis of dsRNA expression levels of the GM trait, and the data concerning the
observable effects on non-target organisms (NTO) will provide the necessary evidence
for ensuring safety of species exposed to RNAi plants. Bioinformatics may provide
support to risk assessment by selecting target gene sequences with low similarity to.org June 2020 | Volume 11 | Article 9401
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Frontiers in Plant Science | www.frontiersinthe genome of NTOs possibly exposed to dsRNA. The analysis of these topics in risk
assessment indicates that the science-based regulatory process in Europe is considered
to be applicable to GM RNAi plants, therefore the evaluation of their safety can be
effectively conducted without further modifications. Outcomes from the present paper
offer suggestions for consideration in future updates of the EFSA Guidance documents on
risk assessment of GM organisms.Keywords: RNA interference, biosafety, food safety, genetically modified plants, bioinformatics, non-target
organisms, GMO regulationINTRODUCTION
In the last decade, a variety of new biotech methods have been
developed, offering great technical potential for use in the
agricultural sector. The European Union has established a legal
framework to ensure that the application of modern
biotechnology, and more specifically of genetically modified
organisms (GMO), is developed under safe conditions.
According to the EU legislation on GMO, in particular
Regulation (EC) No 1829/2003 on genetically modified (GM)
food & feed and Directive 2001/18/EC on deliberate release into
the environment of GMO, every application for commercial use
of a GMO has to be approved by the European Commission after
a safety assessment. This assessment is conducted by the
applicants according to the requirements of either of the two
laws. For the preparation of dossiers, applicants need to conduct
appropriate experimental studies and literature searches for
collecting information regarding human and animal health, as
well as environmental safety. The data requirements according to
EU legislation on GMOs are laid down in the implementing
Regulation No 503/2013 and Commission Directive (EU) 2018/
350 for food/feed and environmental safety respectively. Support
for applicants in preparing dossier for the commercialization of
GM products is guaranteed by specific guidance documents
(GDs) issued by the European Food Safety Authority (EFSA
Panel on GMO, 2010; EFSA Panel on GMO, 2011) and
periodically updated or supplemented by specific statements
following the latest scientific developments in the field. As new
biotech products are being developed, it is important that the
rationale for the safety assessment is built on a scientific
consideration of the characteristics of the new products in
accordance with the principles of the EFSA GDs.
The RNA-interference (RNAi) technique exploits a natural
mechanism present in almost all eukaryotic organisms, which
leads to the loss of functionality of a gene by blocking the
messenger RNA (mRNA) molecules essential for the formation
of a protein. The RNA expression constructs are normally
delivered as transgenes, via plant transformation or as a part of
virus‐vectors (Yin et al., 2005), and therefore, they are required
to undergo GMO regulatory procedures to enable authorization
for commercial use. However, unlike classical GM plants that are
generally modified to express a specific protein, GM plants
expressing dsRNA (hereafter, RNAi plants) do not need to
express novel proteins to produce a new phenotype. RNAi
plants have been modified to express double stranded RNA.org 2(dsRNA) molecules that enable specific post-transcriptional
partial or complete silencing of plant target genes or target
genes from plant pathogens or pests.
RNAi can be used in a “within species” mode to improve
plant composition by removing or reducing anti-nutrients,
allergens and toxins while enhancing levels of beneficial
nutrients, and to improve plant growth and productivity by
suppressing undesirable traits. The same mechanism can be
exploited by expressing dsRNA in plants that silence genes in
other organisms exposed to the plants (Zotti et al., 2018). Virus
resistant and insect resistant plant varieties obtained using RNAi
mechanisms have already been approved for cultivation outside
Europe (e.g. papaya resistant to Papaya Ringspot Virus in USA,
Canada and Japan; plum tree resistant to plum pox virus (PPV)
approved in the USA; common bean resistant to Bean Golden
Mosaic Virus (BGMV) in Brazil; SmartStax™ maize with
multiple resistance traits, including dsRNA against Diabrotica
virgifera virgifera approved in the USA and Canada), cassava
resistant to Brown Streak Virus and Ugandan Cassava Brown
Stick Virus in Nigeria. In the EU, several RNAi plants with
enhanced nutritional characteristics including Soybean
DP305423 and soybean MON87705 with increased oleic acid
acid have been authorised for placing on the market with the
exception of cultivation. More recently, EFSA has given a
positive opinion for import and processing of products derived
from corn rootworm resistant GM maize MON87411 (EFSA
Panel on GMOs, 2018). No applications for cultivation of plants
producing dsRNA have been submitted so far to European
authorities. However, EFSA has published an opinion on a GM
potato event with antisense-mediated gene silencing
(EFSA, 2006).
As knowledge in this field is rapidly accumulating, EFSA has
supported the publication of 3 systematic literature searches and
reviews, summarizing the available information on RNAi
technology to support the risk assessment of RNAi plants
(Paces et al., 2017; Christiaens et al., 2018; Dàvalos et al.,
2019). While these studies did not directly offer any
recommendations for risk assessment, they offer valuable
baseline information supporting any future risk assessment
framework. Previously, EFSA had also organized an
international workshop on “Risk assessment considerations for
RNAi-based GM plants” (European Food Safety Authority,
2014) which also led to a number of external peer-reviewed
publications discussing the risk assessment considerations of
these plants (Ramon et al., 2014; Casacuberta et al., 2015).June 2020 | Volume 11 | Article 940
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meeting publication (USEPA, 2014), these publications form
the first wave of risk assessment considerations.
In the field of pest management, RNAi applications are
exploring completely novel mechanisms of actions, as has been
shown from work on RNAi plants as well as from direct
applications of dsRNA as pesticide product. Effective examples
are: silencing of the DvSnf7 gene, which results in suppression of
mRNA encoding the class E vacuolar sorting protein in D. v.
virgifera (Bachman et al., 2013); targeting of vacuolar-ATPase
subunit A (v‐ATPase A) in D. v. virgifera (Baum et al., 2007) and
in Bemisia tabaci (Thakur et al., 2014) by the expression of
dsRNA. Furthermore, examples of RNAi-based control to
manage filamentous fungal plant pathogens are steadily
increasing (Machado et al., 2018). Progress in the development
of RNAi plants and also new RNA-based biopesticides is
expected to bring to the market new plant varieties or plant
protection products within a few years (Taning et al., 2020).
The COST Action iPlanta (iplanta.univpm.it) is the largest
network of European scientists actively engaged in research on
RNAi systems and applications, including host-induced gene
silencing (HIGS) and spray induced gene silencing (SIGS).
Among the goals of iPlanta are the identification of the specific
biosafety data requirements for the risk assessment and risk
management of RNAi plants and their products (i.e. food and
feed) and the elucidation of knowledge gaps arising in the area of
potential food and feed and/or environmental risks specific to
RNAi applications.
The present paper is the result of an iPlanta working group
activity and aims to discuss the relevance and applicability of the
existing EFSA GMOGuidelines for environmental and food/feed
risk assessment for RNAi plants. Starting from some key
elements of the EFSA GDs, the paper discusses the
applicability of the principles of the GDs to RNAi plants and,
based on the considerations of their scientific aspects involved,
suggests the data requirements considered significant for
preparation of dossiers.COMPARATIVE ASSESSMENT
In the EFSA GDs, comparative safety assessment is indicated as a
general principle for the risk assessment of GM plants. The GDs
therefore suggest optimal methodologies for data collection on
relevant assessment endpoints, to compare GM plants and
derived food and feed, with their respective comparators (e.g. the
near isogenic control line). The comparative safety assessment of
GMplants is considered effective to identify differences to their non-
GM counterparts and assess the consequences of these differences.
Comparative safety assessment is based on data collected for
molecular characterization, the agronomic and phenotypic
characteristics of the GM plant, as well as its compositional
analysis. In addition, the comparative safety assessment within
environmental risk assessment (ERA) requires information on
the interactions of the GM plant with other biota and its
receiving environment(s).Frontiers in Plant Science | www.frontiersin.org 3The main requirements and questions raised by the EFSA GD
are the following:
• Describe how the tested GM line was produced (breeding
tree);
• Document that the selected conventional counterpart is
genetically as close as possible to the GM line and has a
history of safe use;
• Select (a minimum of 8) experimental sites for conducting
field experiments concerning compositional, agronomic and
phenotypic analysis, where the meteorological and agronomic
conditions reflect the ones under which the crop is to be
grown;
• Select appropriate plant genotypes, e.g. the GM line genetic
background to ensure the quality and stability of the selected
test material;
• Include in the field experiments the GM line(s), the near
isogenic control and 3 reference commercial varieties at each
site (minimum 6 different varieties in total), on the basis of
having adequate statistical power to detect differences or
equivalence;
• Indicate the measurement endpoints to be used;
These power calculations depend respectively on the typical
variability found between small agronomic plots used for food-
feed trials and between the larger plots typically employed for
environmental trials (see EFSA Panel on Genetically Modified
Organisms, 2010; EFSA Panel on Genetically Modified
Organisms, 2011).
In neither case is the methodology of the field trial assessment
related to the technology adopted to produce the novel plant or
food under assessment. For the above-mentioned points, it is
considered that the implementation of field experiments for
RNAi plants will not be different from all currently grown
GM events.
It could be problematic to field test RNAi plants with
tolerance to extremes of environmental conditions such as
temperature, salinity and soil moisture, but this is also the case
for other GM plants. In addition, comparative field testing in the
presence of a target pathogen or pest may not be easily realized.
For instance, in the case of virus resistant RNAi plants
interactions between GM plants and the targeted viruses have
to be assessed in preliminary tests. It is also important to
consider that the composition of an RNAi plant may be altered
after the attack by a specific pest or pathogen due to general and
dsRNA- specific defence responses, which may change plant
physiology/metabolism (Eschen-Lippold et al., 2012).
Consequently, specially designed field studies located in
regions with high pathogen or pest pressure are useful to
assess the safety of newly introduced plant or pest resistance
mechanisms under typical cultivation conditions and to detect
any possible unintended effects.
The current EFSA GD have been used mostly to consider
applications for herbaceous GM plants. However perennial
RNAi plants such as virus resistant RNAi GM trees (e.g.
Rainbow papaya, Ferreira et al., 2002, Honey sweet plum,
Scorza et al., 2013), may require other measurement endpointsJune 2020 | Volume 11 | Article 940
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comparative field studies for safety evaluations (Aguilera
et al., 2013).
In some applications (e.g. virus resistance in GM trees)
dsRNA can be used for transforming rootstocks so that the
effects occur in the whole plant, because of the translocation of
siRNA into scions grafted to the transformed rootstocks (Limera
et al., 2017; De Francesco et al., 2020). Several studies
demonstrated the transfer of siRNAs from the transgenic
rootstock to the nontransgenic scion conferring resistance to
virus in fruit trees (Zhao and Song, 2014) and grafted cucumber
(Bai et al., 2016). This technology is now studied also for
conferring resistance to pests (Taning et al., 2020) and diseases
(Sabbadini et al., 2019). Such systemic silencing probably
depends on amplification of siRNAs through secondary siRNA
production. However, in contrast to highly expressed or aberrant
RNAs (such as viral RNAs or RNA from transgenes),
endogenous plant mRNAs are usually not prone to secondary
siRNA production (Luo and Chen, 2007; Baeg et al., 2017) and to
systemic silencing (Frizzi and Huang, 2010; Dadami et al., 2014).
Therefore, translocation of siRNAs to scions and fruits and the
usage of grafting technologies will be available only for
specific applications.MOLECULAR CHARACTERIZATION
According to the strategy of the EFSA GDs, following a case-
specific problem formulation, the risk assessment starts with the
comprehensive molecular characterization of the GM plant
under scrutiny.
The main areas on which information is required during the
molecular characterization are:
• Information on the intended genetic modification which includes:
the transformation process (method of transformation; recipient
plant tissue; details of Agrobacterium strain used, helper plasmids
etc.); the source of DNA and design of vector constructs (sequence
of DNA to be inserted, codon optimisation, promoters etc.); the
role of each functional element
• Information on the GM plant, including: the trait(s) modified;
the transgene constructs actually present in the GM plant;
protein characterization and equivalence; expression and
stability of the insert.
• Bioinformatics data/open reading frame analysis to identify
potential for newly created toxins/allergens.
These data also inform the risk analysis of horizontal gene
transfer (see below).
Data concerning the transformation process and the sequence
and function of the inserted DNA for RNAi plants are not
different from other transgenic events. Also, where the RNAi
event possesses additional conventional transgenes for selection
etc., the normal data requirements still apply to those parts.
However, for the inserted dsRNA cassette specifically, some of
the data normally required for GM plants simply cannot beFrontiers in Plant Science | www.frontiersin.org 4obtained. For instance, data related to newly expressed proteins,
protein equivalence and the codon optimization are irrelevant
for this inserted DNA as long as no part is translated into
protein. Data on levels of dsRNA expression over time and
plant development stages in different tissues and environmental
conditions relevant for the crop in question will be necessary to
estimate exposure of humans and other animals to the dsRNA in
food or feed. dsRNA levels in plant tissues are also dependent on
the type of transformation. In nuclear transformants dsRNA is to
a large part processed in plant cells into siRNAs (Frizzi and
Huang, 2010) which are not efficiently taken up by insects. In
contrast, transplastomic plants accumulate dsRNA within the
chloroplasts (Bally et al., 2016), resulting in high amounts of
unspliced dsRNA in green plant parts (Zhang et al., 2015) and
may therefore be used particularly for targeting leaf-feeding
insect pests. Exposure of organisms to dsRNA through roots,
tubers and pollen, however, is low in transplastomic RNAi
plants, which implies that nuclear transformants and
transplastomic plants are likely to have different risks for non-
target organisms (Schiemann et al., 2019). Bioinformatics
analyses offer the availability of additional measurement
endpoints, which can be potentially more specific for events
transformed with dsRNA. According to EU implementing
regulation 503/2013, bioinformatics analyses are requested for
the recipient plant genome to detect potential off-target plant
genes that might be suppressed unintentionally. Considerations
including a set of parameters that allow the prediction of possible
off-target transcripts in plants have been published by the EFSA
GMO Panel (EFSA GMO Panel (2017) Annex II of the minutes
of the 118th GMO Plenary meeting: Internal note on the strategy
and technical aspects for small RNA plant off-target
bioinformatics studies. Available at: https://www.efsa.europa.
eu/sites/default/files/event/171025-m.pdf). On a case-by-case
basis and depending on the function of the potential off-
targets, additional data may be required for safety assessment.
Such information could also be considered, although with a
more limited value, for estimating possible off-target effects in
outcrossing plant species or non-target organisms in the
receiving environment, however this is feasible only when
relevant genomic information is available on organisms
exposed to the GM plant or its dsRNA.
A key benefit of the sequence-based mechanism of action for
RNAi plants for pest control is the possibility to achieve a high
degree of specificity to the target organism while not harming
exposed valued NTOs in the agroecosystem (Bramlett et al.,
2020). Bioinformatics are informative for the selection of regions
within target genes that possess high divergence across species,
thus allowing for the selection of gene sequences specific to the
target pest and minimizing the potential for homology to NTOs
that are potentially exposed to the GM plants or its products. In
order to achieve this, the search for 21bp homologies between the
dsRNA and possible target sequences in NTOs is a good starting
point, but the exact length and sequence of the construct that
may produce gene suppression in different invertebrate species
are not precisely known. Paces et al. (2017) indicates that while
siRNA-target base pairing is highly specific, mismatches do notJune 2020 | Volume 11 | Article 940
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type of mismatch. Furthermore, available literature is in
disagreement regarding the minimum effective base pairs
length, number and location of allowed mismatches
(Christiaens et al., 2018). SiRNAs also appear to vary in length
in different insect species. A recent research paper looking at
siRNA populations after viral infections showed two tested
lepidopteran species having predominantly 20nt siRNAs while
siRNAs in the examined orthopteran and hymenopteran species
were mostly 22nt long (Santos et al., 2019). This could imply that
the necessary homology for successful RNAi silencing could
differ between species as well. Coleoptera typically have 21nt
long siRNAs and research experience supporting the
development of the MON87411 maize with dsRNA targeting
the DvSnf7 gene, indicates that shorter than 21 nt sequence
length shared between the dsRNA construct and the target gene
(19, 20 bp) did not result in an efficient silencing effect in the
target insect (Bachman et al., 2013).
Finally, it must be noted that little sequence information is
available for many NTOs and factors other than sequence
homology (e.g. successful uptake and stability of the dsRNA
molecules into the insect, accessibility of the mRNA site of
action) may affect the efficacy of siRNA. Therefore, it may be
necessary to generate data on the effects of the dsRNA on
exposed NTOs during ERA. This is discussed below.FOOD/FEED SAFETY ASSESSMENT
The main pillars on which is based the safety assessment of food/
feed containing or derived from GMOs according to the EFSA
GD (EFSA Panel on GMO, 2011) are:
• Toxicological assessment of newly expressed proteins and/or
new constituents other than proteins;
• Assessment of allergenicity of the newly expressed proteins
and the new plant;
• Safety assessment of altered levels of food and feed
constituents;
• Safety assessment of the whole food and/or feed derived from
GM plants;
• Nutritional assessment of food/feed derived from GM plants.
No new proteins are intended to be produced by the dsRNA
cassette in RNAi plants, therefore the toxicological assessment of
newly expressed proteins is not relevant for food/feed products
derived from them. Consequently, since all known food allergens
are proteins, the allergenicity can also generally be considered
not a relevant concern for RNAi plants, unless expression of
genes coding for enzymes involved in the metabolism of existing
plant allergens are silenced in the GM plant.
Compositional analyses can then constitute the key
requirement for analysing the effects of identified differences,
as well as for nutritional evaluation of food and feed derived from
RNAi plants. Indeed, major metabolic changes in comparison
with the near-isogenic control plants can be detected withFrontiers in Plant Science | www.frontiersin.org 5compositional analyses, for which international standards are
available and commonly applied for food safety assessment. For
instance, the Organisation for Economic Co-operation and
Development (OECD) consensus documents on the safety
assessment of transgenic organisms (http://www.oecd.org/env/
ehs/b iotrack/sa fe tyassessmentof transgenicorganism
soecdconsensusdocuments.htm, accessed on 12 December 2019)
include proximates (comprising moisture and total ash), key
macro- and micro-nutrients, anti-nutritional compounds,
natural toxins, and allergens, as well as other plant metabolites
characteristic for the plant species.
For the safety assessment of whole food/feed, animal feeding
trials are recommended by EFSA only on a case-by-case basis,
specifically those cases for which the quality of available
analytical data does not allow excluding possible safety issues
for the specific product or fail to demonstrate nutritional
equivalence with its comparator. While 90-days feeding studies
are deemed effective methods to detect toxic effects of single
substances, there has been considerable discussion over their
relevance and sensitivity for the detection of potential
unintended effects of whole food and feed. It is considered
unlikely that substances present in small amounts and with a
low toxic potential will result in any observable unintended
effects in a 90-day rodent feeding study (EFSA, 2008).
However, following the adoption of the Implementing
Regulation (EU) 503/2013, a 90-day study in rodents on whole
food/feed is required for all GM plant products in the EU. This
new legal requirement changes the assessment from a
hypothesis-driven case-by-case exercise, as originally indicated
by the EFSA GD.
Exposure to dsRNA and siRNA through GM RNAi plant-
derived food/feed by humans and farm animals is estimated to be
low, due to some considerations regarding the metabolism of
organisms ingesting exogenous RNA (Dàvalos et al., 2019). First
of all, the uptake of ingested exogenous nucleic acids is limited by
biological barriers in the gastro-intestinal (GI) tract, such as
degradation by nucleases or an impaired cellular uptake (e.g.
O’Neill et al., 2011; Petrick et al., 2013). Moreover, RNA
absorption from the GI tract remains questionable (Jain, 2008;
Thompson et al., 2012). Even if ingested siRNA is absorbed from
the GI tract, it is normally rapidly degraded within the
cardiovascular system and cleared through liver and kidneys
(Christensen et al., 2013). These barriers represent the main
difficulty for the development of targeted human RNAi drugs
(e.g. Vaishnaw et al., 2010) which require specific formulations to
deliver siRNA into the target cells. Consequently, it is unlikely
that siRNA concentrations from GM RNAi plants will be
sufficient to exert biologically relevant effects in mammals. In
order to lead to harmful effects, the uptake of dsRNA should be
followed by the delivery in sufficient quantity and in an active
form to trigger RNAi and there would also need to be sufficient
sequence complementarity with an mRNA transcript in the
targeted cells (Roberts et al., 2015). Therefore, the risk of
unwanted gene silencing in humans and animals upon
ingestion of food/feed derived from RNAi plants can be
considered negligible.June 2020 | Volume 11 | Article 940
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The EFSA GD on Environmental Risk Assessment (EFSA Panel
on GMO, 2010) requires a safety evaluation regarding different
specific areas of concern.
• Persistence and Invasiveness
Cultivated plants may persist in the environment even after
harvest and some crop species have wild relatives with which
they can hybridize allowing genes to flow from crops into other
species. However, gene flow frequency and its consequences are
very variable. For instance, gene flow is already an important
issue in open pollinating plants with common wild relatives
e.g., rice and beet but not in predominantly self-pollinating
species such as wheat or beans. The focus of the ERA is on the
expected consequences of gene flow, once it happens.
The information needed for assessing consequences of plant
transformation on persistence and invasiveness is based on the
following points in order to analyse the possibility of
environmental harm:Frontier◦ Understand the biological features of the plant that has
been genetically modified (e.g. life cycle, dispersal, gene
flow, persistence, invasiveness, etc.);
◦ Analyse how the transgene affects the phenotype,
behaviour, and interaction of the GM plant with the
hybridizing wild relatives present in the receiving
environment.The likelihood of increased persistence of the RNAi plant and
recipient wild relatives in the environment is linked to the expressed
traits of the GM plant, therefore the assessment for RNAi plants is
similar to that of other GM plants and is case by case.
The possibility of off-target effects in wild relatives of the
GM plant could be estimated starting from the provided
bioinformatics results and the acquired characteristics of the
transformed plant species. Bioinformatics could be helpful as a
predictive tool to detect possible off-target sequence alignment
considering the similarities between the genome of the GM
donor crop and the recipient plant. However, information on
the genome of the wild relatives might be only partially
available or completely lacking in the scientific literature.
If transgene transfer to a wild relative occurs, then NTOs
associated with the wild plant may be exposed to the dsRNA and
should be considered in the safety assessment. The expression
and environmental persistence of dsRNA in different tissues over
time needs attention, as their environmental stability is expected to
be different (Christiaens et al., 2018). However, this exposure
pathway is not specific to RNAi plants as similar data may be
required for GM plants expressing other biologically active
compounds such as Cry proteins.
• Horizontal Gene Transfer
The main issues to be considered in this case are:
◦ Molecular characterization of the DNA sequences
inserted in the plant, including information on the
potential of the promoter elements that could drive
expression in microorganisms;s in Plant Science | www.frontiersin.org 6◦ presence of antibiotic resistance marker (ARM) genes;
◦ presence of recipient microorganisms for transgenic
DNA in the receiving environments;
◦ presence of inserted DNA sequences showing homologies
with DNA sequences from relevant microbial recipients,
enhancing the probability of recombination, or mobile
elements in the vicinity of the insertion site which could
enhance the potential for gene transfer;
◦ selective conditions enhancing the probability of
dissemination and maintenance of the genetic
material from GM plants in natural microbial
communities (e. g. the presence of antibiotics in the
receiving environment(s);
◦ environmental persistence of GM plant material after
harvesting;
◦ potential for long-term establishment of the genetic
materials from GM plants in microbial communities;
◦ ecological or human/animal health consequences of a
potential HGT from a GM plant to microorganisms
(e.g. potential spread of antibiotic resistance genes and
probability of reduced efficiency of antibiotic
treatments in humans);
◦ information on the prevalence and distribution of
genes identical or similar to the transgene in
microorganisms in natural environments.The likelihood of DNA transfer to bacteria is generally
independent of the function of the DNA sequence, therefore
the probability is the same as for other transgenes. However,
integration of transferred DNA into the bacterial genome by
homologous recombination depends on sequence homologies.
For sequences that encode dsRNA targeting genes of plants or
plant pests the likelihood for sufficient sequence homologies to
a bacterial genome is rather low. As for other GM plants, if
regulatory sequences from bacteria are present in the transgene
construct (like the nopaline synthase promoter and terminator
from Agrobacterium tumefaciens), they may provide
homologies necessary for integration into the genome of
microorganisms. Maintenance of transferred DNA in bacteria
is dependent on the encoded trait and on possible selective
conditions (i.e. transfer of an antibiotic resistance marker gene
can allow a selective advantage in the presence of the respective
antibiotic). One of the differences between RNAi plants and a
conventional GM plant is that the newly inserted DNA does
not code for a protein. This implies that in case of horizontal
DNA transfer from RNAi plants to bacteria no new functions
will be acquired through expression of a novel protein. In
addition, bacteria do not possess the RNAi machinery that is
homologous to eukaryote cells so targeted modification of gene
expression is not easily possible.
Gene transfer is a rare event, but frequency may increase if
there is positive selection of the transferred sequences to levels
where it may be relevant. Potential ecological consequences due
to the transfer to microorganism of a gene or trait that is
already widespread in the environment (like many of the ARM
genes) need to be estimated case by case; however, also this
aspect is not specifically related to RNAi plants.June 2020 | Volume 11 | Article 940
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authorized in non-EU countries (e.g Rainbow papaya 55-1,
Arctic™ apple), antibiotic resistance marker genes are included
in the cassette (http://www.isaaa.org/gmapprovaldatabase/default.
asp); however, there are no reports concerning negative effects on
the spread of ARM genes in the environments where these crops
are being cultivated. Other RNAi events were obtained without
insertion of ARM genes in the cassette. This prevents concerns for
possible spreading of ARM genes and can be confirmed with
molecular characterization of every newly developed event.
Exposure characterization steps are similar for all GM
plants, no specific additional requirements are deemed
necessary and the existing requirements are considered
equally applicable.
• Target and Non-Target Organisms
The main questions raised by the EFSA ERA GD are the
following:
Target OrganismsFrontier- Data on the exposure of target organisms to the GM
plant;
- Data on the potential for resistance development in the
target organisms.Exposure data describing dsRNA expression in different
plant parts are derived from the compositional and molecular
characterisation of GM RNAi plants as previously discussed.
This will show possible exposure levels of targeted plant pests
and pathogens throughout the growing season and post-harvest
in seeds, plant biomass and plant debris. dsRNA may be
designed to have sub-lethal effects on target species, for
example by preventing mature development or inducing
sterility. Thus in vivo studies involving in planta exposure are
required to determine effects at both individual and population
level.
Continuous or repeated exposure exerts a selection pressure
which can promote onset of resistance in target pest
populations. RNAi mechanisms are not an exception to this
general rule. Khajuria et al. (2018) reported the first known case
of a pest resistant to a mechanism of gene silencing. The
authors selected in laboratory conditions a strain of the
western corn rootworm, D. v. virgifera resistant to dsRNA
targeting DvSnf7 gene, through exposure to GM maize MON
87411. The study demonstrated that the resistance mechanism
is based on an altered uptake of RNAmolecules and individuals
of this colony showed cross-resistance also to other dsRNA
tested in their experiments.
Though the insurgence of resistance in target organisms
represents mainly an agronomic problem, a possible drawback
for the environment is the fact that the spread of a resistant
strain could damage crop species in the area and then require
additional use of pesticides. Data necessary for estimating the
potential for resistance development in target organisms refer
to the biology of target organisms (e.g. allele frequency, fitness,
mobility). Data requirements for estimating the exposure of
target organisms pertain to the ecology of the pest species and
the levels of exposure to dsRNA in plant parts. In cases of RNAi
plants where a dsRNA targets an insect pest gene and the plants in Plant Science | www.frontiersin.org 7also expresses a Cry toxin targeting the pest (e.g. as in maize
MON 87411), the insects ability to develop resistance to the
GM plant will be influenced. The resistance management
strategies of EFSA (EFSA, 2015) apply here, and post release
monitoring plans should therefore consider the likelihood of
resistance development to such pyramided or stacked traits.
In planta tests are applicable for the study of pathogen
resistance induced via RNAi (Rosa et al., 2018), for instance, by
modulating the expression of membrane surface proteins. This
type of response has to be tested in actively growing plants as
surface protein responses may vary with plant development,
and this may have different impacts on the infectivity of
pathogens.
Non-Target Organisms
The steps needed to conduct an environmental safety
assessment according to the EFSA ERA GD are the following:
◦ Collection of available knowledge of the environments
and ecosystems likely to be exposed to the RNAi plants
or plant parts or to hybridising relatives;
◦ Selection of NTO focal species to be tested based on the
presence and ecological relevance of the species
occurring in receiving environments of the GM plant,
their sensitivity to the potential stressor and likely to be
exposed to the dsRNA either through the GM plant or
food chains;
◦ selection of measurement endpoints representative for
protection goals;
◦ setup experimental protocols for bioassays to assess
direct and indirect effects on selected NTO;
◦ data collection for estimating the exposure of NTOs to
the dsRNA in GM plant and food chains.The criteria for the selection of non-target focal species are
based on the ecology of the NTOs, therefore no different
assessment is needed compared to any other GM events,
however bioinformatics can provide support to the selection
procedure. Information on the presence of the same gene
sequences targeted by the dsRNA in the genome of NTO can
be used to select species potentially sensitive to the dsRNA
expressed in GM plants. However, sequence match does not
necessarily mean risk as the organism possess digestive and other
physiological barriers that degrade/exclude the dsRNA from
being taken up. Given the large variability in RNAi efficacy in
invertebrates, even between closely related species sometimes,
the species’ sensitivity to RNAi could also be taken into account
during the selection procedure. Species known as being barely
sensitive to dsRNA after oral uptake are less valuable as NTOs in
risk assessment.
In order to estimate the exposure potential of NTOs, in
addition to some pheno-ecological characteristics of the NTO
and its host plants (e.g. host spatial distribution and life cycle,
overlap of NTO and plant life cycle) it is necessary that the
presence of dsRNA/siRNA in plant tissues over time is estimated.
While the full-length dsRNA is expressed in plants and can be
reliably measured across tissues, the endemic dicer in plants will
result in pools of siRNAs. siRNA estimates may not be relevant,
since they are not expressed, but become biologically availableJune 2020 | Volume 11 | Article 940
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levels of siRNAs in plant tissues would likely be pools and
therefore of limited biological impact, which can be better
assessed with bioassays. Measuring the dsRNA instead, can
provide a better estimate for exposure, based on the
assumption that no greater number of siRNAs would be
present than starting dsRNA. The important information is the
minimum amounts of dsRNA required to initiate siRNA
silencing activity, once that threshold is reached there may not
be a direct correlation between quantities of dsRNA and activity
levels. Therefore, quantification of full-length dsRNA provides
the most appropriate exposure value for NTOs.
Organisms at the third trophic level (e.g. parasitoids,
predators), can also be exposed indirectly to dsRNA by feeding
on herbivore hosts/preys. The movement and the residual
activity of dsRNA at the third trophic level was detected by
Garbian et al. (2012) in Varroa destructor individuals feeding on
Apis mellifera. It is known that some predator species show
sensitivity to dietary RNAi upon ingestion (Haller et al., 2019),
however the occurrence of such effects if exposed to a natural
feeding regime (i.e. ingestion of prey feeding on dsRNA
containing diet and pollen) in controlled conditions needs to
be confirmed. To date the tritrophic bioassay with Varroa mites
represents the only studied case in which exposure at the third
trophic level was experimentally demonstrated and therefore
specific bioassays will be needed to prove actual exposure of non-
target carnivores.
Experimental protocols for evaluating effects on NTOs may
need to be adapted to the case of RNAi plants. The most relevant
route of exposure for NTOs in nature is likely to be oral
exposure. A different effect can be obtained in some cases,
when dsRNA is directly injected into the body of specimen
toxic or supplied via ingestion (Powell et al., 2017). Therefore,
toxicity tests should incorporate a dietary exposure to the test
substance to ensure physiological exposure of specimen to
dsRNA. A designed NTO study of sufficient length should
allow for the elucidation of sublethal and lethal effects. Apical
endpoints such as growth, development, reproduction/fecundity,
and mortality are clearly linked to population level effects in
NTOs and thus can be related back to protection goals.
Sub-lethal effects need to be duly considered, as gene silencing
is expected in many cases not to induce acute lethal effects, but
alteration of the physiology of target organisms may lead to a
delayed effect and/or induce transient effects (e.g. Vargas et al.,
2008; Kumar et al., 2012). In addition, studies of gene expression
in the tested species where a matching sequence with the dsRNA
has been observed in genomic analyses can ensure that the
possible effect is indeed caused by silencing and not by
environmental conditions during testing, which may affect
gene expression in the target/non-target species.
In planta tests may also be necessary to ensure that safety for
NTOs is demonstrated under environmental conditions that
allow optimal gene expression in NTOs exposed to (near
isogenic) control plants as well as test plants (Arpaia et al.,
2017). Information regarding susceptibility of ‘control’ specimen
in different conditions is then to be provided.Frontiers in Plant Science | www.frontiersin.org 8Another case in which in planta tests are applicable for ERA,
is the study of pathogen resistance induced via RNAi, for
instance, by modulating the expression of membrane surface
proteins. This type of proteins cannot be tested in isolation,
therefore in planta tests can be effectively used to assess impacts
on NTOs (e.g. endophytic and mycorrhizal fungi) exposed
directly or indirectly to dsRNA in GM plants.
Also in this area of ERA of RNAi plants, an additional source
of available information in support to ERA is the availability of
bioinformatics tools. However, due to the limited availability of
genome sequencing for non-target organisms, and the restricted
predictability of RNAi off-target genes in animals, bioinformatics
cannot reliably determine the possibility of unintended silencing
effects on those species but may represent a first screening, which
may need further confirmation with the support of more
traditional toxicity bioassays. Routinely screening the genomes
of non-target organisms to identify genes that might be silenced,
may not be practical due to the absence of sequence information
on many NTOs. It may be possible to collect relevant
information from the observation of off target silencing in the
intended target species in order to estimate potential effects on
NTOs, especially if they are taxonomically close to the
target species.STACKED EVENTS
In some cases, GM RNAi plants may be transformed to express
more than one dsRNA, for example to silence a plant gene to
confer a quality change as well as pest resistance. In these cases,
the risk assessment should follow the EFSA guidance approach
(EFSA, 2007) and carefully consider whether any interactions
occur between the transgenes and/or the traits that may alter
their expression or effects on targets and non-targets. For
example, silencing a plant gene which has antifeedant activity
may render the plant more susceptible to pests and thus affect
pest plant relationship.
In addition, GM RNAi plants may contain transgenes
conferring activity against the same or other pests and
pathogens and providing other characteristics such as herbicide
tolerance. For example maize MON 87411 expresses dsRNA
targeting DvSnf7 gene in Diabrotica spp., is also transformed to
express a Cry3 toxin lethal to the same species. Other GM RNAi
plants may contain transgenes stacked by hybridisation of lines
with single and numbers of events such as other pest resistance
genes, herbicide tolerance or other complimentary traits (e.g.
maize MON87427×MON89034×MIR162×MON87411). In
these cases the non RNAi GM events require the normal risk
assessment procedures and so no changes in data requirements
are envisaged for plants containing stacked RNAi and non-RNAi
events for both ERA and food/feed safety evaluation. However,
the risk assessments should carefully consider whether any
interactions occur between the transgenes and/or traits, which
may alter their expression or effects on target and non-target
organisms. In the case of maize MON 87411 the expression of
both the dsRNA and Cry3 toxin will result in different effects inJune 2020 | Volume 11 | Article 940
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exposure of Diabrotica individuals to dsRNA through feeding,
whereas Diabrotica with some resistance to Cry 3 will feed for
longer and receive higher doses of dsRNA. Studies of non-target
organisms should consider the effects of both traits together
where they are combined in single events.
In GM plants with events stacked by hybridisation it is also
important to note that there can be segregation of events in
subsequent generations. As advised in the EFSAGuidance note on
stacks (EFSA, 2007), all potential novel combinations of events
should be risk assessed as well as the stack and the single events.DISCUSSION
Genetically modified plants expressing interfering RNAs
represent a new generation of GM plants for which more
applications for commercialization are expected in the near future.
Some aspects of their physiology make them quite different from the
“first generation” of currently marketed GM plants expressing a few
phenotypic traits (mostly insect resistance via expression of Cry
toxins or herbicide tolerance). For instance, RNAi plants for insect
resistance exploit completely new mechanisms of action (e.g.
targeting the endosomal sorting complexes required for insect
cellular transport in the SmartStaxPro® maize).
Therefore, in species with significant sequence similarity,
underlying physiological mechanisms need to be considered in
the context of the overall mechanism of action and previous
history of use for products targeting some physiological
functions in plant-dwelling organisms. Knowledge gaps (for
example possible effects of the dsRNA in non-target organisms
as well as off-target effects in the plant genome) need to be
specifically tackled by applicants during risk assessment.
In their evaluation of Monsanto’s GM maize MON 87411 and
the stack, MON 89034 x TC1507 x MON 87411 x DAS-59122-7
combined trait maize (SmartStax® PRO) expressing a dsRNA
targeting the Western Corn Rootworm Snf7 gene, USEPA
reviewed the extensive data set provided by the applicant on the
effects of dsRNA in the context of its application in agriculture.
In considering potential human health risks from the dsRNA,
USEPA’s risk assessment was based on the evidence provided,
including a 28-day toxicology study on the dsRNA, supporting
the findings from a USEPA Scientific Advisory Panel (USEPA,
2014; USEPA, 2016a). The report indicated that “no reliable
evidence that exogenous dsRNAs are taken up from the gut”
existed. The Panel concluded that the combination of RNAses
and acids founds in the human digestive system ensure that all
forms of RNAs expressed in plant material and consumed by
humans are likely to be degraded.
When considering the ecological risk assessment of DvSnf7
RNA in the GM maize events, USEPA analyzed the battery of
laboratory tests on non-target organisms including invertebrate
predators, parasitoids, pollinators, soil biota, and aquatic and
terrestrial vertebrate species. Data presented were considered a
reasonable framework for future environmental assessments of
pesticide products based on environmental dsRNA (USEPA,Frontiers in Plant Science | www.frontiersin.org 92017). As a new mode of action was involved, the DvSnf7
RNA ecological risk assessment was also reviewed by a FIFRA
Science Advisory Panel (SAP). Several aspects of the risk
assessment approach, including exposure assumptions,
environmental fate and non-target effects data, on toxicity and
possible synergism with stacked Bt traits were considered.
Furthermore, the risk assessment went on to state that “in
silico evaluations are not considered to be predictive of adverse
effects” (USEPA, 2017), and that such evaluations are currently
only considered as supplemental information to provide
additional evidence for risk determination.
Taken together, the data in support of the approval of GM
maize events were considered adequate by EPA and they concluded
that the application of RNAi-based mode of action for pest control
in agriculture presents minimal hazard and risk to non-target
organisms with protection goals (USEPA, 2016b; USEPA, 2017).
Likewise, Food Standard Australia and New Zealand applies a
case-by-case approach to GM food safety assessment, which is
considered sufficiently broad and flexible to address the safety of
GM foods developed using gene silencing techniques such as
RNAi technology (FSANZ, 2013).
The EFSA GDs are the technical support for applicants
conducting risk assessment of GM plants according to the
European legislative framework. The GDs indicate the general
principles for conducting risk assessment, purposefully leaving
room for selecting the necessary information for preparing
dossiers case by case.
In this paper, we considered the main principles described in
the current EFSA GDs for risk assessment of GM plants, to
determine which areas of the existing risk assessment approaches
for GM plants are appropriate or could be refined, and if
complementary or alternative risk assessment strategies need to
be developed for RNAi plants in the EU. We aimed at
highlighting the rationale for defining specific biosafety data
requirements for the risk assessment and risk management of
RNAi plants and their derived products (i.e. food and feed).
The outcomes of our analyses, suggest that data requirements
for the risk assessment of RNAi plants will be similar to other
GM plants and therefore the risk assessment framework used so
far for other GM plants is still valid. Likewise, the case by case
approach depending on plant species, event and trait also applies
for case specific post market monitoring. Guidelines for risk
assessment cannot be “cookbooks” and some flexibility should be
left for risk assessors to adapt and justify the details of their
assessment. It is up to regulatory agencies to judge the validity of
risk assessment approaches and support applicants in delivering
estimates of risk at the highest safety standard, considering the
severity and the likelihood of possible impacts on human, animal
and environmental safety.
The approach outlined in this paper could provide support to
future updates of the EFSA GDs, since there is not yet much
experience, especially for environmental risk assessment, of
RNAi plants. In particular, we wish to highlight a few
characteristics of RNAi mechanisms, which need consideration
during specific steps of the risk assessment (e.g. molecular
characterization, NTO species selection).June 2020 | Volume 11 | Article 940
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Risk assessment of RNAi plants may need less data in some steps
of the process. For instance, the molecular analysis and
comparative compositional analyses between the GM plants
and their comparators might show that no new proteins are
produced and endogenous protein levels are unchanged. In this
case, assessment of toxicity and allergenicity of new plant
products are unnecessary. However according to the
implementing regulation (EU 503/2013), 90-days feeding
studies on rodents are currently mandatory regardless of the
additional data available from chemical analyses and
their interpretation.
The Role of Bioinformatics
Bioinformatics may have an important role in supporting the
risk assessment of RNAi plants, e.g. through opportune
comparisons of the genomes (even if only partially known) of
target and relevant non-target organisms which might be
exposed to the interfering RNA in the field. In fact, a
thoughtful design of dsRNA at the beginning of the process of
development of new RNAi plants, can limit the possibility of
non-target effects due to sequence similarity (USEPA, Scientific
Advisory Panel, 2014). It is known that the taxonomic and
genomic proximity of target and non-target species renders
silencing effects more likely (Christiaens et al., 2018), however
the extent of these effects may be variable between species in the
same family (Haller et al., 2019). The limited availability of insect
genomes in currently accessible databases further limits the
predictive ability of bioinformatics, so that supporting data for
an absence of non-target effects needs to be obtained through
bioassays. However, results from bioinformatics analyses may
contribute to build a weight of evidence on the safety assessment
of RNAi plants.
Specifically Tailored Bioassays
Experimental protocols for bioassays may need to be adapted in
order to achieve the required sensitivity in detecting possible
effects. While exposing test specimens in laboratory conditions to
dsRNA via injection is a useful tool for elucidating silencing
mechanisms, this pathway cannot be considered biologically
relevant for estimating in vivo exposure of TOs and NTOs in
nature; therefore ingestion of RNAi plant tissues or diet-
incorporated dsRNA should be adopted for testing NTOs.
Experimental conditions should ensure that the expression of
the target gene is optimal in the specimen not exposed to dsRNA
containing diet for the whole duration of the test. Enzymatic
barriers in some species may degrade dsRNA, so the silencing
effect in a given species might not occur in other taxa. Additional
measurement endpoints (e.g. measurement of expression of the
target gene) can increase confidence on the results of the
bioassays. For instance, an analysis of silencing effects on
the target gene (and possibly on a few essential off-target genes
with sequence similarities) can clarify the physiological
mechanisms determining phenotypical characters (i.e.
mortality and sub-lethal effects).Frontiers in Plant Science | www.frontiersin.org 10Observations of the presence of dsRNA in different tissues
and over the growth period of plants will be necessary to estimate
exposure of target and some selected non-target organisms. In
addition, data will be required on expression levels of dsRNA in
TOs to enable the selection of significant pathways necessary to
estimate exposure of their natural enemies to the dsRNA.
A special remark concerns the risk assessment of GM RNAi
trees, some of which have already been authorized for
commercialization outside the EU. Though it is not unique for
RNAi-based events, the possible applications for commercial
release of GM rootstocks will need a reflection on what kind of
information will be needed regarding scions, and consequently
on the fruits produced by such varieties. Current European
regulation states that if part of a plant is GM then the whole
plant is designated as GM. Consequently, a product of a GM
plant, even if does not contain transgenic DNA, is classified as
GM. In the European system, approval is given for a GM event.
Once the event is approved it can be put into any genetic
background through hybridization. For instance, if the same
GM Prunus rootstock is used for plum, cherry, peach, apricot
scions, then no new application is required.
Finally, reference is to be made to the recent developments of
RNAi-based pesticide products for external application. While
these products are subject to pesticide regulation, risk assessment
requirements and protocols are likely to be derived from
experiences with GM RNAi plants. However, there are some
unique aspects, which will have to be considered for externally
applied RNAi products, such as issues of plant uptake, effect of
chemical modifications, carriers or formulations on dsRNA
stability, the effects of stabilizing measures on the exposure and
impacts of non-target species (Taning et al., 2020).CONCLUSIONS
A working group of the COST Action iPlanta discussed the main
aspects, relevance and applicability of the principles of the
existing EFSA guidelines to environmental and food/feed risk
assessment for RNAi plants. The authors consider that the
current science-based regulatory process in Europe is still
applicable to RNAi plants; nevertheless, the assessment process
should permit some flexibility for risk assessors to adapt and
justify the case-by-case assessment of their RNAi plants.
We highlight the following considerations linked to the
peculiarity of RNAi GM plants that could be also considered
for further updates of the existing EFSA Guidance Documents on
risk assessment for GMOs:
• The data related to newly expressed proteins, protein
equivalence and the codon optimization are irrelevant for
the inserted DNA as long as no part is translated to protein.
Consequently, the food and feed safety assessment could be
simplified with regard to novel proteins and their potential
allergenicity if no novel proteins are produced. Intended as
well as unintended effects triggered by siRNA in the plant can
be detected by compositional analyses and, where applicable,
nutritional evaluation of food and feed derived from RNAiJune 2020 | Volume 11 | Article 940
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through dietary dsRNA/siRNA are highly unlikely because of
rapid degradation in the GI tract and several barriers to
cellular uptake in mammals. The data on levels of dsRNA
expression over time, in different plant tissues and related to
environmental conditions during the experiments are
necessary for estimating the possible exposure to the
dsRNA in plants or derived food or feed for consumers and
non-target organisms in the receiving environment;
• Bioinformatics can offer a good support to risk assessment,
especially when designing dsRNA sequences specific to the
target gene and minimizing the potential for off-target
binding sites. Due to the limitations in genome sequences
for NTOs, for ERA bioinformatics analyses should be
complemented with specifically developed bioassays and
measurement of gene suppression.AUTHOR CONTRIBUTIONS
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